A share price of MBX Biosciences Inc [MBX] is currently trading at $12.26, up 8.98%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MBX shares have gain 5.33% over the last week, with a monthly amount drifted -24.69%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MBX Biosciences Inc [NASDAQ: MBX] stock has seen the most recent analyst activity on October 08, 2024, when Stifel initiated its Buy rating and assigned the stock a price target of $40. Previously, JP Morgan started tracking the stock with Overweight rating on October 08, 2024, and set its price target to $30. On October 08, 2024, Jefferies initiated with a Buy rating and assigned a price target of $35 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $44 on October 08, 2024.
MBX Biosciences Inc experienced fluctuations in its stock price throughout the past year between $9.42 and $27.50. Currently, Wall Street analysts expect the stock to reach $44 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $12.26 at the most recent close of the market. An investor can expect a potential return of 258.89% based on the average MBX price forecast.
Analyzing the MBX fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.57 points at the first support level, and at 10.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.59, and for the 2nd resistance point, it is at 14.92.
Ratios To Look Out For
To put it in perspective, the Current Ratio for MBX Biosciences Inc [NASDAQ:MBX] is 25.75. Further, the Quick Ratio stands at 25.75.
Transactions by insiders
Recent insider trading involved Hawryluk P. Kent, President & CEO, that happened on Feb 04 ’25 when 50000.0 shares were purchased. Director, Mathers Edward T completed a deal on Sep 16 ’24 to buy 0.5 million shares. Meanwhile, 10% Owner BASKETT FOREST bought 0.5 million shares on Sep 16 ’24.
